Lenalidomide+Dexamethasone (Rd), Lenalidomide Not-Refractory, Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), 1,2,3 prior line of therapy, Phase 3, Dexamethasone+Lenalidomide+Carfilzomib (KRd)
### Instruction:
Identify the study with the following condition. 
### Input:
Lenalidomide+Dexamethasone (Rd), Lenalidomide Not-Refractory, Proteasome Inhibitors (PI), Relapsed Refractory Multiple Myeloma (RRMM), 1,2,3 prior line of therapy, Phase 3, Dexamethasone+Lenalidomide+Carfilzomib (KRd) 
### Output:
Popular Name is ASPIRE, Study ID is NCT01080391